Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Danyi Lu has a total of 105 co-authors. Here are the top co-authors by number of shared publications:

  • Baojian Wu

    Institute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou 510006, China

    22 shared publications
  • Shuai Wang

    Guangzhou University of Chinese Medicine

    8 shared publications
  • Dong Dong

    School of Medicine, Jinan University, Guangzhou, China

    7 shared publications
  • Baojian Wu

    Institute of Molecular Rhythm and Metabolism, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China

    5 shared publications
  • Tianpeng Zhang

    Research Center for Biopharmaceutics and Pharmacokinetics, College of Pharmacy (T.Z., M.Z., D.L., S.W., F.Y., L.G., B.W.), and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research (T.Z., B.W.), Jinan University, Guangzhou, China; and School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China (S.W.).

    5 shared publications
  • Zhiguo Ma

    Division of Pharmaceutics, College of Pharmacy (H.S., X.Z., D.L., Z.M., B.W.) and Guangzhou Jinan Biomedicine Research and Development Center, Jinan University, Guangzhou, China (X.W.)

    5 shared publications

Latest Publications

  • Open Access

    Lysionotin enhances circadian rhythm and accelerates the recovery of DSS-induced colitis in mice by targeting the circadian clock component RORα

    by Caimei Wu, Jiahao Xu, Dihao Xie, Meixue Luo, Simin Zhong, Mengting Zhang, Jianning Liang, Ruoyan Zheng, Shuai Wang, Baojian Wu, et al.

    Background and Purpose : Circadian clock disruptions are implicated in various pathological processes, including inflammatory diseases such as ulcerative colitis (UC). Restoring or enhancing the molecular circadian clock represents a promising therapeutic strategy. Lysionotin (LYS), a natural polymethoxyflavone, was investigated for its potential role in modulating circadian rhythms and mitigating colitis. Experimental Approach : LYS was screened for circadian-amplifying effects using human U2OS cells stably expressing Per2-dLuc or Bmal1-dLuc reporters. Its interaction with RORα was assessed through luciferase reporter assays, cellular thermal shift assays (CETSA), and molecular docking. In vivo efficacy was evaluated in a DSS-induced colitis mouse model, with assessments of disease activity index (DAI), histopathology, cytokine levels, and clock gene expression. In vitro studies using LPS-stimulated DLD-1 cells further examined anti-inflammatory mechanisms and RORα dependency. Key Results : LYS significantly enhanced circadian amplitude in U2OS cells without altering periodicity. It directly bound to RORα, increased its thermostability, and activated BMAL1 transcription in a RORα-dependent manner. In DSS-induced colitis mice, LYS treatment accelerated recovery, reduced DAI scores, improved histopathology, lowered proinflammatory cytokines, and restored expression of circadian clock proteins (e.g., BMAL1, PER2, REV-ERBα). In vitro , LYS suppressed LPS-induced NF-κB activation and cytokine production via RORα. Conclusion and Implications : LYS functions as a novel RORα agonist and circadian enhancer that ameliorates experimental colitis by reinforcing circadian rhythms and suppressing NF-κB-mediated inflammation. These findings support the further development of RORα-targeting polymethoxyflavones as chronotherapeutic agents for inflammatory bowel diseases.

  • Disruption of local circadian clocks in aristolochic acid-induced nephropathy in mice

    by Dihao Xie, Simin Zhong, Meixue Luo, Jiahao Xu, Ruoyan Zheng, Jiading Luo, Yiting Wang, Yongxing Guo, Lianxia Guo, Baojian Wu, et al.


  • Kinetic Characterization of Estradiol Glucuronidation by Liver Microsomes and Expressed UGT Enzymes: The Effects of Organic Solvents

    by Caimei Wu, Meixue Luo, Dihao Xie, Simin Zhong, Jiahao Xu, Danyi Lu

    Background and Objective In vitro glucuronidation of 17β-estradiol (estradiol) is often performed to assess the role of uridine 5′-diphospho-glucuronosyltransferase 1A1 (UGT1A1) in xenobiotic/drug metabolism. The objective of this study was to determine the effects of four commonly used organic solvents [i.e., dimethyl sulfoxide (DMSO), methanol, ethanol, and acetonitrile] on the glucuronidation kinetics of estradiol, which can be glucuronidated at C3 and C17 positions. Methods The impacts of organic solvents on estradiol glucuronidation were determined by using expressed UGT enzymes and liver microsomes from both human and animals. Results In human liver microsomes (HLM), methanol, ethanol, and acetonitrile significantly altered estradiol glucuronidation kinetics with increased Vmax (up to 2.6-fold) and CLmax (up to 2.8-fold) values. Altered estradiol glucuronidation in HLM was deduced to be attributed to the enhanced metabolic activities of UGT1A1 and UGT2B7, whose activities differ at the two glucuronidation positions. The effects of organic solvents on estradiol glucuronidation were glucuronidation position-, isozyme-, and solvent-specific. Furthermore, both ethanol and acetonitrile have a greater tendency to modify the glucuronidation activity of estradiol in animal liver microsomes. Conclusion Organic solvents such as methanol, ethanol, and acetonitrile showed great potential in adjusting the glucuronidation of estradiol. DMSO is the most suitable solvent due to its minimal influence on estradiol glucuronidation. Researchers should be cautious in selecting appropriate solvents to get accurate results when assessing the metabolism of a new chemical entity.


  • Regulation of BCRP expression and sulfasalazine pharmacokinetics by the nuclear receptor REV-ERBα

    by Chunhong Wu, Yifei Xiao, Caimei Wu, Dihao Xie, Meixue Luo, Dingyi Yao, Min Chen, Danyi Lu

    BCRP (breast cancer resistance protein) is a crucial efflux transporter involved in the regulation of the pharmacokinetics and pharmacodynamics of a wide range of drugs. Herein, we aimed to investi...


  • Open Access

    Puerariae lobatae radix protects against UVB-induced skin aging via antagonism of REV-ERBα in mice

    by Luyao Ma, Meiping Huang, Guanghui Sun, Yanke Lin, Danyi Lu, Baojian Wu

    Puerariae lobatae radix (PLR) is a wildly used herbal medicine. Here we aimed to assess the PLR efficacy against UVB (ultraviolet-B)-induced skin aging and to determine the mechanisms thereof. We found a significant protective effect of PLR (topical application) on UVB-induced skin aging in mice, as evidenced by reduced skin wrinkles, epidermal thickness, and MDA (malondialdehyde) content as well as increased levels of HYP (hydroxyproline) and SOD (superoxide dismutase) in the skin. In the meantime, Mmp-1, p21 and p53 levels were decreased in the skin of PLR-treated mice. Anti-aging effects of PLR were also confirmed in L929 cells. Furthermore, PLR up-regulated skin expression of BMAL1, which is a known regulator of aging by promoting Nrf2 and antioxidant enzymes. Consistently, Nrf2 and several genes (i.e., Prdx6, Sod1, and Sod2) encoding antioxidant enzymes in the skin were increased in PLR-treated mice. Moreover, based on Gal4 chimeric assay, Bmal1 reporter gene and expression assays, we identified PLR as an antagonist of REV-ERBα that can increase Bmal1 expression. Intriguingly, loss of Rev-erbα protected mice against UVB-induced skin aging and abrogated the protective effect of PLR. In conclusion, PLR acts as an antagonist of REV-ERBα and promotes the expression of BMAL1 to protect against skin aging in mice.


  • Pharmacokinetics-based Chronotherapy

    by Danyi Lu, Zhigang Wang, Baojian Wu

    Dosing time-dependency of pharmacokinetics (or chronopharmacokinetics) has been long recognized. Studies in recent years have revealed that daily rhythmicity in expression of drug-metabolizing enzymes and transporters (DMETs) are key factors determining chronopharmacokinetics. In this article, we briefly summarize current knowledge with respect to circadian mechanisms of DMETs and discuss how rhythmic DMETs are translated to drug chronoeffects. More importantly, we present our perspectives on pharmacokinetics-based chronotherapy.


  • Involvement of REV-ERBα dysregulation and ferroptosis in aristolochic acid I-induced renal injury

    by Yi Wang, Zhigang Wang, Zhengping Wu, Menglin Chen, Dong Dong, Pei Yu, Danyi Lu, Baojian Wu


  • A novel pyrrole-imidazole polyamide targets Aurora kinase A and suppresses tumor growth in vivo

    by Meiqing Li, Danyi Lu, Yulian Cheng, Chunlei Wu, Jianchao Zhang, Wenli Shi, Zhihao Ding, Yanyan Li, Binghua Cheng, Xian Lin, et al.


  • Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase

    by Ximing Shao, Zhihao Ding, Wenhua Zhou, Yanyan Li, Zhibin Li, Haodong Cui, Xian Lin, Guoli Cao, Binghua Cheng, Haiyan Sun, et al.

    Although nanomaterials have shown promising biomedical application potential, incomplete understanding of their molecular interactions with biological systems prevents their inclusion into mainstream clinical applications. Here we show that black phosphorus (BP) nanomaterials directly affect the cell cycle’s centrosome machinery. BP destabilizes mitotic centrosomes by attenuating the cohesion of pericentriolar material and consequently leads to centrosome fragmentation within mitosis. As a result, BP-treated cells exhibit multipolar spindles and mitotic delay, and ultimately undergo apoptosis. Mechanistically, BP compromises centrosome integrity by deactivating the centrosome kinase polo-like kinase 1 (PLK1). BP directly binds to PLK1, inducing its aggregation, decreasing its cytosolic mobility and eventually restricting its recruitment to centrosomes for activation. With this mechanism, BP nanomaterials show great anticancer potential in tumour xenografted mice. Together, our study reveals a molecular mechanism for the tumoricidal properties of BP and proposes a direction for biomedical application of nanomaterials by exploring their intrinsic bioactivities.


  • Open Access

    Chronotoxicity of Semen Strychni is associated with circadian metabolism and transport in mice

    by Lu Gao, Yanke Lin, Shuai Wang, Luomin Lin, Danyi Lu, Yue Zhao, Huijie Xing, Baojian Wu

    We aimed to determine the circadian responses of mice to Semen Strychni and to investigate the role of pharmacokinetics in generating chronotoxicity. Total extract of Semen Strychni was administered by oral gavage to wild-type (WT) and Bmal1−/− (a circadian clock-deficient model) mice at different circadian time points for toxicity (including survival) and pharmacokinetic characterization. Nephrotoxicity and neurotoxicity were evaluated by measuring plasma creatinine and creatine kinase BB (CK-BB), respectively. Drug metabolism and transport assays were performed using liver/intestine microsomes and everted gut sacs, respectively. Semen Strychni nephrotoxicity and neurotoxicity as well as animal survival displayed significant circadian rhythms (the highest level of toxicity was observed at ZT18 and the lowest level at ZT2 to ZT6). According to pharmacokinetic experiments, herb dosing at ZT18 generated higher plasma concentrations (and systemic exposure) of strychnine and brucine (two toxic constituents) compared with ZT6 dosing. This was accompanied by reduced formation of both dihydroxystrychnine and strychnine glucuronide (two strychnine metabolites) at ZT18. Bmal1 ablation sensitized mice to Semen Strychni-induced toxicity (with increased levels of plasma creatinine and CK-BB) and abolished the time dependency of toxicity. Metabolism of Semen Strychni (strychnine and brucine) in the liver and intestine microsomes of WT mice was more extensive at ZT6 than at ZT18. These time differences in hepatic and intestinal metabolism were lost in Bmal1−/− mice. Additionally, the intestinal efflux transport of Semen Strychni (strychnine and brucine) was more extensive at ZT6 than ZT18 in WT mice. However, the time-varying transport difference was abolished in Bmal1−/− mice. Circadian responses of mice to Semen Strychni are associated with time-varying efflux transport and metabolism regulated by the circadian clock (Bmal1). Our findings may have implications for optimizing phytotherapy with Semen Strychni via timed delivery.